Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study

MASAAKI MURAKAWA, NAOTO YAMAMOTO, YUTO KAMIOKA, MARIKO KAMIYA, SATOSHI KOBAYASHI, MAKOTO UENO, MANABU MORIMOTO, YOSUKE ATSUMI, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA and SOICHIRO MORINAGA
In Vivo January 2020, 34 (1) 347-353; DOI: https://doi.org/10.21873/invivo.11780
MASAAKI MURAKAWA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.murakawa{at}kcch.jp
NAOTO YAMAMOTO
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUTO KAMIOKA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIKO KAMIYA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SATOSHI KOBAYASHI
2Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO UENO
2Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANABU MORIMOTO
2Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSUKE ATSUMI
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORU AOYAMA
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI TAMAGAWA
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NORIO YUKAWA
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YASUSHI RINO
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MUNETAKA MASUDA
3Department of Surgery, Yokohama City University, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SOICHIRO MORINAGA
1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 34 no. 1 347-353
DOI 
https://doi.org/10.21873/invivo.11780
PMID 
31882498

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received October 15, 2019
  • Revision received October 30, 2019
  • Accepted November 5, 2019
  • Published online December 27, 2019.

Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. MASAAKI MURAKAWA1⇑,
  2. NAOTO YAMAMOTO1,
  3. YUTO KAMIOKA1,
  4. MARIKO KAMIYA1,
  5. SATOSHI KOBAYASHI2,
  6. MAKOTO UENO2,
  7. MANABU MORIMOTO2,
  8. YOSUKE ATSUMI3,
  9. TORU AOYAMA3,
  10. HIROSHI TAMAGAWA3,
  11. NORIO YUKAWA3,
  12. YASUSHI RINO3,
  13. MUNETAKA MASUDA3 and
  14. SOICHIRO MORINAGA1
  1. 1Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan
  2. 2Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan
  3. 3Department of Surgery, Yokohama City University, Yokohama, Japan
  1. Correspondence to: Masaaki Murakawa, Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ward, Yokohama city, 241-8515, Japan. Tel: +81 455202222, e-mail: m.murakawa{at}kcch.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 12 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

In Vivo
Vol. 34, Issue 1
January-February 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
20 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study
MASAAKI MURAKAWA, NAOTO YAMAMOTO, YUTO KAMIOKA, MARIKO KAMIYA, SATOSHI KOBAYASHI, MAKOTO UENO, MANABU MORIMOTO, YOSUKE ATSUMI, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, SOICHIRO MORINAGA
In Vivo Jan 2020, 34 (1) 347-353; DOI: 10.21873/invivo.11780

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study
MASAAKI MURAKAWA, NAOTO YAMAMOTO, YUTO KAMIOKA, MARIKO KAMIYA, SATOSHI KOBAYASHI, MAKOTO UENO, MANABU MORIMOTO, YOSUKE ATSUMI, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, SOICHIRO MORINAGA
In Vivo Jan 2020, 34 (1) 347-353; DOI: 10.21873/invivo.11780
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Can D3 Lymph Node Dissection for Patients With Colon Cancer With a Poor C-Reactive Protein/Albumin Ratio Improve Survival Outcomes?
  • Google Scholar

More in this TOC Section

  • Clinical Evaluation Versus Clinical Evaluation With Dermoscopy in Malignant Skin Neoplasms Diagnosis
  • Clinical Utility of Body Weight Monitoring During Cisplatin-based Chemotherapy
  • NLRP3 and RANK-RANKL-OPG Pathway-related Gene Expression Levels in Children With Autism Spectrum Disorder
Show more Clinical Studies

Keywords

  • pancreatic ductal adenocarcinoma
  • CRP/Alb ratio
  • prognostic factor
In Vivo

© 2026 In Vivo

Powered by HighWire